Promoter holding
64.27%
VP
Visakha Pharmacity Limited - Due diligence report
A 360° intelligence report on Visakha Pharmacity Limited: trust score, financial health, credit view, compliance, directors, growth and dist…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Visakha Pharmacity Limited — 360° Intelligence Report
Generated from MCA filings & public records80/100
Trust Score
Low Risk
Visakha Pharmacity Limited is assessed as Low Risk with a Trust Score of 80/100. Visakha Pharmacity Limited is an active public limited indian non-government company incorporated in 2004, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 26 Jul 2026 from the latest processed filings. Visakha Pharmacity Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 55/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- No open charges - unencumbered balance sheet.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 4 satisfied (298.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Axis Bank Limited | 2 | 48.0 cr |
| Infrastructure Development Finance Company Limited | 1 | 48.0 cr |
| State Bank Of Hyderabad | 1 | 48.0 cr |
Compliance Score: 86/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 2 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| DIVAKAR MARRI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| EMANDI SANKARA RAO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Kesava Datta Nanduri | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHATAPURAM VENKATARAMANI MAHESHWARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| POPURI PANDARI LAL KRISHNA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SIVA SATYANARAYANA REDDY MANDA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MURAHARI REDDY VELPULA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ESHWAR REDDY PURMANDLA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| POPURI PANDARI LAL KRISHNA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Satyam Naidu Attada | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAVIKUMAR REDDY SOMAVARAPU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 11 directors on the board.
- CHATAPURAM VENKATARAMANI MAHESHWARI has DIN status "Disqualified by RoC u/s 164(2)".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Ramky Infrastructure Limited
Subsidiaries
4
Group entities
4
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Jnpc Pharma Innovation Limited | Subsidiary Company | 74.00% |
| Receps Limited | Subsidiary Company | 74.00% |
| Visakha Energy Limited | Subsidiary Company | 74.00% |
| Visakha Pharma Innovation And Incubation Limited | Subsidiary Company | 74.00% |
| Ramky Infrastructure Limited | Holding Company | 74.00% |
Key managerial personnel: POPURI PANDARI LAL KRISHNA (CEO) · POPURI PANDARI LAL KRISHNA (CEO) · Satyam Naidu Attada (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Asset base grew 2.1x - capacity expansion.
Operating for 22+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 24% in a year.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence82/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
Investor view78/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events11 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
04 Sep 2023
Director ceased
CHATAPURAM VENKATARAMANI MAHESHWARI
05 Aug 2023
Director appointed
CHATAPURAM VENKATARAMANI MAHESHWARI (Director)
09 Nov 2022
Director ceased
ISAAC WESLEY VIJAYAKUMAR
08 Sep 2022
Director ceased
EMANDI SANKARA RAO
02 Feb 2022
Director appointed
EMANDI SANKARA RAO (Director)
31 Aug 2021
Director ceased
MURAHARI REDDY VELPULA
05 Aug 2021
Director appointed
MURAHARI REDDY VELPULA (Director)
Director ceased
DONTHIREDDY HIMAVARDHAN REDDY
14 Jun 2021
Director appointed
Kesava Datta Nanduri (Company Secretary)
03 Jun 2021
Director appointed
SIVA SATYANARAYANA REDDY MANDA (Nominee Director)
Director ceased
PRATHAP PATHAKAPALU
29 Jan 2021
Charge satisfied
Axis Bank Limited
28 Aug 2020
Director ceased
RAVIKUMAR REDDY SOMAVARAPU
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
11 active director(s) / partner(s); review board churn before relying on management continuity.
2 active GST registration(s) indicate ongoing business operations.
All 4 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 4 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| M. Moser Associates | U20296DL2007PTC171291 | New Delhi, Delhi, India |
| Comacoe | U45205MH1995PLC085797 | Mumbai, Maharashtra, India |
| Cobratecton Private Limited | U41000TN2020PTC134909 | Chennai, Tamil Nadu, India |
| Nalanda Engicon Private Limited | U45205BR2007PTC013270 | Patna, Bihar, India |
| Shinryo Suvidha | U74899DL1983PTC016594 | New Delhi, Delhi, India |
| Cinda Engineering & Construction | U45208DL2008FTC181860 | New Delhi, Delhi, India |
| Ray Engineering | U45201MH2006PTC164846 | Mumbai, Maharashtra, India |
| Maccaferri Environmental Solutions Private Limited | U45200PN1998PTC131124 | Pune, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Visakha Pharmacity Limited before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Visakha Pharmacity Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 75/100, margin trends, ownership structure and peer set for Visakha Pharmacity Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Visakha Pharmacity Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Visakha Pharmacity Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Visakha Pharmacity Limited an active company?
Visakha Pharmacity Limited has MCA status “Active” with a compliance score of 86/100 (Low Risk).
Is Visakha Pharmacity Limited financially healthy?
Visakha Pharmacity Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.
Should I do business with Visakha Pharmacity Limited?
Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Visakha Pharmacity Limited?
The ultimate holding entity is Ramky Infrastructure Limited. 11 active director(s) are on record.
Does Visakha Pharmacity Limited have loans or charges against its assets?
No open charges - all 4 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Visakha Pharmacity Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).
Is it risky to lend to Visakha Pharmacity Limited?
Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
